US Bancorp’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.3K | Sell |
487
-20
| -4% | -$1.77K | ﹤0.01% | 2753 |
|
|
2025
Q4 | $40.7K | Buy |
507
+43
| +9% | +$3.6K | ﹤0.01% | 2784 |
|
|
2025
Q3 | $45.3K | Hold |
464
| – | – | ﹤0.01% | 2720 |
|
|
2025
Q2 | $32.3K | Sell |
464
-504
| -52% | -$28.8K | ﹤0.01% | 2978 |
|
|
2025
Q1 | $48.1K | Buy |
968
+134
| +16% | +$8.47K | ﹤0.01% | 2769 |
|
|
2024
Q4 | $58.3K | Sell |
834
-3,297
| -80% | -$274K | ﹤0.01% | 2663 |
|
|
2024
Q3 | $433K | Buy |
4,131
+490
| +13% | +$57.3K | ﹤0.01% | 1591 |
|
|
2024
Q2 | $518K | Buy |
3,641
+1,781
| +96% | +$205K | ﹤0.01% | 1454 |
|
|
2024
Q1 | $207K | Sell |
1,860
-135
| -7% | -$16.1K | ﹤0.01% | 1990 |
|
|
2023
Q4 | $259K | Buy |
1,995
+495
| +33% | +$68.2K | ﹤0.01% | 1888 |
|
|
2023
Q3 | $245K | Buy |
1,500
+140
| +10% | +$24.6K | ﹤0.01% | 1739 |
|
|
2023
Q2 | $249K | Buy |
1,360
+230
| +20% | +$33.1K | ﹤0.01% | 1765 |
|
|
2023
Q1 | $151K | Buy |
1,130
+363
| +47% | +$42.6K | ﹤0.01% | 2001 |
|
|
2022
Q4 | $60.9K | Sell |
767
-26
| -3% | -$1.83K | ﹤0.01% | 2423 |
|
|
2022
Q3 | $47K | Buy |
793
+139
| +21% | +$8.98K | ﹤0.01% | 2565 |
|
|
2022
Q2 | $36K | Buy |
654
+106
| +19% | +$6.14K | ﹤0.01% | 2759 |
|
|
2022
Q1 | $41K | Buy |
548
+48
| +10% | +$3.28K | ﹤0.01% | 2717 |
|
|
2021
Q4 | $37K | Sell |
500
-9
| -2% | -$533 | ﹤0.01% | 2801 |
|
|
2021
Q3 | $24K | Sell |
509
-259
| -34% | -$11.3K | ﹤0.01% | 3026 |
|
|
2021
Q2 | $31K | Buy |
+768
| New | +$31.8K | ﹤0.01% | 2899 |
|
|
2020
Q3 | – | Sell |
-1,670
| Closed | -$47K | – | 3685 |
|
|
2020
Q2 | $47K | Buy |
1,670
+1,531
| +1,101% | +$37.3K | ﹤0.01% | 2446 |
|
|
2020
Q1 | $3K | Buy |
+139
| New | +$3.23K | ﹤0.01% | 3350 |
|
|
2018
Q4 | – | Sell |
-65
| Closed | -$1K | – | 3577 |
|
|
2018
Q3 | $1K | Buy |
65
+8
| +14% | +$165 | ﹤0.01% | 3541 |
|
|
2018
Q2 | $1K | Buy |
+57
| New | +$1.25K | ﹤0.01% | 3532 |
|
|
2018
Q1 | – | Sell |
-853
| Closed | -$24K | – | 3595 |
|
|
2017
Q4 | $24K | Hold |
853
| – | – | ﹤0.01% | 2862 |
|
|
2017
Q3 | $23K | Buy |
+853
| New | +$18.9K | ﹤0.01% | 2835 |
|
|
2015
Q4 | – | Sell |
-59
| Closed | -$1K | – | 3586 |
|
|
2015
Q3 | $1K | Hold |
59
| – | – | ﹤0.01% | 3479 |
|
|
2015
Q2 | $1K | Sell |
59
-12,974
| -100% | -$150K | ﹤0.01% | 3470 |
|
|
2015
Q1 | $124K | Buy |
+13,033
| New | +$135K | ﹤0.01% | 2027 |
|
Other funds holding ACLS
VPM
RP
VCM
US Bancorp's ACLS Position: Q1 2026 in Review
US Bancorp reduced its Axcelis (ACLS) stake by 3.9% in Q1 2026, selling an estimated $1.77K and leaving 487 shares worth $45.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2753.
US Bancorp first reported a position in ACLS in Q1 2015 and has held it in 29 quarters since. The position peaked at $518K in Q2 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- US Bancorp held 487 shares of Axcelis worth $45.3K as of Q1 2026.
- US Bancorp sold 20 Axcelis shares in Q1 2026, an estimated $1.77K.
- Axcelis made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #2753 holding.
- US Bancorp first reported a position in Axcelis in Q1 2015 and has held it in 29 quarters since.
- US Bancorp's Axcelis position peaked at $518K in Q2 2024.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.